Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.51 |
| ▸ | GLA | P06280 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 4/20 | 0.46 |
| ▸ | TP53 | P04637 | 3/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | PPARG | P37231 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 3/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.37 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21990717 | 0.91 | ALDH1A1 (0.44) | ALDH1A1GLATSHRTP53HIF1A | |
| SCHEMBL20678995 | 0.85 | ALDH1A1 (0.45) | ALDH1A1GLATSHRTP53HIF1A | |
| SCHEMBL8373583 | 0.84 | ALDH1A1 (0.47) | ALDH1A1GLATSHRTP53HIF1A | |
| SCHEMBL23731175 | 0.84 | ALDH1A1 (0.47) | ALDH1A1GLATSHRTP53HIF1A | |
| SCHEMBL13033300 | 0.84 | ALDH1A1 (0.51) | ALDH1A1GLATSHRTP53HIF1A | |
| SCHEMBL17900843 | 0.84 | ALDH1A1 (0.51) | ALDH1A1GLATSHRTP53HIF1A | |
| SCHEMBL20258080 | 0.82 | ALDH1A1 (0.46) | ALDH1A1GLATSHRTP53HIF1A | |
| SCHEMBL2718922 | 0.82 | ALDH1A1 (0.48) | ALDH1A1GLATSHRTP53HIF1A | |
| SCHEMBL4897371 | 0.81 | ALDH1A1 (0.65) | ALDH1A1GLATSHRTP53HIF1A | |
| SCHEMBL25246542 | 0.80 | TSHR (0.56) | ALDH1A1GLATSHRTP53HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12630668-B2 | Liquid compression molding material | NAMICS CORPORATION (JP) | 2026-05-19 | — | — | US | disclosed |
| US-20250026920-A1 | LIQUID EPOXY RESIN COMPOSITION FOR USE AS MOLD UNDERFILL MATERIAL FOR TSV | SK Hynix Inc. (KR) | 2025-01-23 | — | — | US | disclosed |
| CN-113056519-B | Curable resin composition and curable sheet | 长濑化成株式会社 | 2024-02-23 | — | — | CN | disclosed |
| US-11760870-B2 | Resin composition for encapsulation | NAGASE CHEMTEX CORPORATION (JP) | 2023-09-19 | — | — | US | disclosed |
| US-11718770-B2 | Curable resin composition and curable sheet | NAGASE CHEMTEX CORPORATION (JP) | 2023-08-08 | — | — | US | disclosed |
| US-20230203236-A1 | LIQUID COMPRESSION MOLDING MATERIAL | NAMICS CORPORATION (JP) | 2023-06-29 | — | — | US | disclosed |
| CN-115668484-A | Liquid compression molding material | 纳美仕有限公司 | 2023-01-31 | — | — | CN | disclosed |
| WO-2021261064-A1 | LIQUID COMPRESSION MOLDING MATERIAL | ナミックス株式会社 | 2021-12-30 | — | — | WO | disclosed |
| US-20210403765-A1 | CURABLE RESIN COMPOSITION AND CURABLE SHEET | NAGASE CHEMTEX CORPORATION (JP) | 2021-12-30 | — | — | US | disclosed |
| CN-113056519-A | Curable resin composition and curable sheet | 长濑化成株式会社 | 2021-06-29 | — | — | CN | disclosed |
| US-8394512-B2 | Phosphaphenanthrene compounds and organic light emitting diode using the same | INKTEC CO., LTD. (KR) | 2013-03-12 | — | — | US | disclosed |
| US-8394512-B2 | Phosphaphenanthrene compounds and organic light emitting diode using the same | INKTEC CO., LTD. (KR) | 2013-03-12 | — | — | US | disclosed |
| US-20110105646-A1 | EPOXY RESIN COMPOSITION FOR ENCAPSULATING ELECTRONIC PART | NAGASE CHEMTEX CORPORATION (JP) | 2011-05-05 | — | — | US | disclosed |
| EP-2280044-A1 | EPOXY RESIN COMPOSITION FOR ENCAPSULATING ELECTRONIC PART | Nagase ChemteX Corporation (JP) | 2011-02-02 | — | — | EP | disclosed |
| US-20100252818-A1 | PHOSPHAPHENANTHRENE COMPOUNDS AND ORGANIC LIGHT EMITTING DIODE USING THE SAME | INKTEC CO., LTD. (KR) | 2010-10-07 | — | — | US | disclosed |
| US-20100252818-A1 | PHOSPHAPHENANTHRENE COMPOUNDS AND ORGANIC LIGHT EMITTING DIODE USING THE SAME | INKTEC CO., LTD. (KR) | 2010-10-07 | — | — | US | disclosed |
| EP-1806376-B1 | HEAT-RESISTANT COMPOSITE MATERIAL | NAGASE CHEMTEX CORP (JP) | 2009-05-13 | — | — | EP | disclosed |
| US-20080139698-A1 | Heat-Resistant Composite Material | NAGASE CHEMTEX CORPORATION (JP) | 2008-06-12 | — | — | US | disclosed |
| US-20080139758-A1 | Epoxy monomers and/or resins and alkali metal salt of weak acid initiator; curing agent free; high polymerization rate and degree; low hygroscopicity thermoplastic polymers; strength, toughness, heat resistance | NAGASE CHEMTEX CORPORATION (JP) | 2008-06-12 | — | — | US | disclosed |
| EP-1806376-A1 | HEAT-RESISTANT COMPOSITE MATERIAL | Nagase Chemtex Corporation (JP) | 2007-07-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100252818-A1 | PHOSPHAPHENANTHRENE COMPOUNDS AND ORGANIC LIGHT EMITTING DIODE USING THE SAME | DDT, PPOX, ODC1 | ALDH1A1 923/4885GLA 3357/4885TSHR 2109/4885 |
| US-12630668-B2 | Liquid compression molding material | PIEZO1, TSNAX, TMCO1 | ALDH1A1 3204/4885GLA 3652/4885TSHR 1046/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.